Researchers at the University of California, Los Angeles (UCLA), in collaboration with pathologists from Hadassah Hebrew ...

Immunohistochemistry (IHC) is a newer technique for assessing the estrogen receptor (ER) status of breast cancers, with the potential to overcome many of the shortcomings associated with the ...

Translational Pathology provides high-plex immunohistochemistry staining (PhenoCycler, aka CODEX), IHC-related image analysis, and expertise services and support in both collaborative and ...

The HER2-low and HER2-ultralow breast cancer subtype designations have led to a changed landscape in HER2-directed therapies, as well as a desire for more sensitive assays that may better quantify ...

Please join Leica Biosystems Life Science Field Applications Specialist Mark Lawson for this special event, where Mark shares the development timeline of IHC and multiplex staining on the BOND RX ...